Brainstorm, Freescale, USAF: Intellectual Property

March 25 (Bloomberg) -- BrainStorm Cell Therapeutics Inc., a developer of adult stem-cell technologies, received a U.S. patent for the use of proprietary stem cells to secrete elevated levels of proteins for treating neurodegenerative diseases.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.